1: Younossi ZM, Karrar A, Pierobon M, Birerdinc A, Stepanova M, Abdelatif D,
Younoszai Z, Jeffers T, Felix S, Jeiran K, Hodge A, Zhou W, Monge F, Alaparthi L, Chandhoke V, Goodman ZD, Petricoin EF. An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in
non-alcoholic fatty liver disease. BMC Med. 2018 Sep 12;16(1):170. doi:
10.1186/s12916-018-1136-1. PubMed PMID: 30205811; PubMed Central PMCID: PMC6134795.

2: Mehta R, Birerdinc A, Wang L, Younoszai Z, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease. BMC Gastroenterol. 2014 Apr 9;14:72. doi: 10.1186/1471-230X-14-72. PubMed PMID: 24716593; PubMed Central PMCID: PMC4021272.

3: Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A, Mehta R, Chandhoke V, Birerdinc A, Younossi ZM. Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome
(PCOS). J Transl Med. 2013 May 31;11:133. doi: 10.1186/1479-5876-11-133. PubMed PMID: 23721173; PubMed Central PMCID: PMC3681627.

4: Page S, Birerdinc A, Estep M, Stepanova M, Afendy A, Petricoin E, Younossi Z, Chandhoke V, Baranova A. Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example. PLoS One. 2013;8(2):e56009. doi: 10.1371/journal.pone.0056009. Epub 2013 Feb 6. PubMed PMID: 23405244; PubMed Central PMCID: PMC3566090.

6: Page S, Chandhoke V, Baranova A. Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation? Obes Rev. 2011 May;12(5):e21-31. doi: 10.1111/j.1467-789X.2010.00773.x. Review. PubMed PMID: 20576005.